Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Labor Long: later-stage trial registry

A small indexed set (3 trials) with no open enrollment listed right now.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count

Labor Long: 3 US clinical trials tracked, none currently recruiting.

Labor Long is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Christiana Care Health Services, running 1 of these trials.

Enrollment posture brief

Registry condition labor-long

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Labor Long (this)0%
Open-enrollment share among volume-matched conditions near Labor Long

Labor Long has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Labor Long on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Labor Long is recruiting below its size-band peers.

    0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Labor Long records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Exogenous oxytocin intravenous infusion Other
1 trials
Electronic breast pump Device
1 trials
Oxytocin (High dose) Drug
1 trials
Oxytocin (Low dose) Drug
1 trials
Mouth Guard Device
1 trials

US sites by state

Facility locations filed on Labor Long trials. A trial with sites in several states counts in each.

Texas 1 trials
Delaware 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Labor Long page

3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Labor Long condition card totals 3 registered trials; most-linked intervention Exogenous oxytocin intravenous infusion; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.